McKesson Corporation is a leading healthcare services and information technology company that specializes in the distribution of pharmaceuticals and medical supplies. The company provides a comprehensive range of services that enhance the efficiency of healthcare systems, including drug distribution to pharmacies, hospitals, and other healthcare providers. Additionally, McKesson offers innovative solutions for managing medical costs, optimizing inventory, and improving patient care through data analytics and technology. By ensuring the timely delivery of critical medical products and services, McKesson plays a vital role in the healthcare ecosystem, supporting both providers and patients. Read More
The biggest companies in the world call the S&P 500 (^GSPC) home, but only a handful are still growing rapidly.
Some of these industry leaders are executing exceptionally well and rewarding shareholders.
McKesson (NYSE: MCK) has outperformed the market over the past 20 years by 5.87% on an annualized basis producing an average annual return of 14.69%. Currently, McKesson has a market capitalization of $91.61 billion.
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential tariffs.
Shares of healthcare distributor and services company McKesson (NYSE:MCK)
jumped 2.6% in the morning session after the positive momentum continued as it raised its profit forecast for fiscal 2026 and boosted its long-term growth targets during its 2025 Investor Day.
Shares of healthcare distributor and services company McKesson (NYSE:MCK)
jumped 6.6% in the morning session after the company raised its profit forecast for fiscal 2026 and boosted its long-term growth targets during its 2025 Investor Day.
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.
McKesson Corporation (NYSE: MCK) will host its 2025 Investor Day today, beginning at 9:30 AM ET. During the event, executive leadership will discuss the company’s multi-year strategic priorities, growth strategies, and long-term business outlook.
McKesson Corporation (NYSE: MCK) today announced changes to its reportable segments and organizational structure, effective in the second quarter of fiscal year 2026. The new reporting structure enhances strategic alignment and transparency, supporting optimizing portfolio management to drive sustainable long-term value creation for shareholders.
Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital.
The select few that can do all three for many years are often the ones that make you life-changing money.
The healthcare industry is currently experiencing a transformative "golden age," a period marked by an unprecedented surge in scientific breakthroughs and technological advancements. This era is fundamentally altering the landscape of medical treatment and diagnostics, promising a future of more personalized, precise, and preventive medicine. At the forefront of this
Shares of healthcare distributor and services company McKesson (NYSE:MCK)
jumped 2.7% in the afternoon session after the company inked a deal with Walmart and USAntibiotics, the nation's only manufacturer of amoxicillin.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at McKesson (NYSE:MCK) and the best and worst performers in the healthcare providers & services industry.
Discover MCKESSON CORP (MCK), an affordable growth stock with strong revenue & earnings growth, a reasonable P/E ratio, and a solid financial foundation.
As the summer fades and financial professionals return to their desks, the specter of the "September Effect"—a historical tendency for stock markets to deliver their weakest performance of the year—looms large over global equities. For September 2025, this seasonal anomaly is amplified by a complex web of economic
The specter of persistent inflation, stubbornly holding above the Federal Reserve's long-term target of 2%, is casting a long shadow over the U.S. economy and financial markets. Recent data reveals a concerning trend where core inflation metrics, stripping out volatile food and energy prices, are accelerating, prompting the central
A wave of innovation is surging through the small-cap markets, with technology, biotech, and energy players making headlines across key growth sectors. From unmanned aircraft battery systems and AI robotics, healthcare, to telecom profitability and sustainable recycling and more, these companies are positioning themselves as disruptive leaders in their fields.
